Aesthetic Botulinum Toxin Injections Incur Severe Resistance Risks

“Aesthetic procedures are by no means immune to botulinum toxin resistance.”

Kyle Seo, M.D., Ph.D., Founder of Modelo Clinic and a first-generation pioneer of botulinum toxin (toxin) therapy in Korea, issued a stark warning. As the scope of toxin applications has expanded well beyond wrinkle correction to encompass multiple areas of the body, the risk of resistance from high-dose, repeated injections can no longer be dismissed.

To substantiate this concern with objective data, Dr. Seo has been systematically documenting suspected resistance cases since 2014. Through clinical resistance testing and blood analysis, he confirmed resistance in as many as 80 patients.

■ Dr. Kyle Seo Validates World's Largest Aesthetic Resistance Dataset

Dr. Seo plans to publish this research as a peer-reviewed paper in the second half of this year. The study is expected to represent the largest dataset on botulinum toxin resistance in the field of aesthetic medicine worldwide — a milestone that is likely to send a strong signal to both clinical practitioners and the aesthetics industry. Until now, most resistance reports in the aesthetic domain have been limited to small case series.

"I concluded that objective, measurable evidence was essential to raise real awareness of toxin resistance," Dr. Seo explained. "Among the 80 patients, 35 underwent blood testing to check for neutralizing antibodies — which are directly linked to resistance — thereby strengthening the objectivity of the data."

■ High-Dose Repeated Injections and Complexing Proteins Drive Toxin Resistance

Analysis of the resistance cases revealed that cumulative total dose from high-dose, repeated injections is a primary driver of resistance risk. The presence of complexing proteins in the formulation was also found to be a contributing factor.

"In patients who switched to a pure toxin formulation — one from which complexing proteins have been removed — no additional resistance cases were observed," Dr. Seo noted.

■ Cosmetic Toxin Resistance Jeopardizes Future Critical Medical Treatment

Dr. Seo repeatedly stressed that resistance developed through aesthetic procedures can have downstream consequences for the treatment of medical conditions. Botulinum toxin is used to treat a range of disorders including hemifacial spasm, cervical dystonia, and post-stroke spasticity. Once neutralizing antibodies form, they circulate systemically and reduce efficacy across all therapeutic indications.

"Resistance not only diminishes cosmetic outcomes — it can also foreclose the option of toxin-based treatment for medical conditions. Prevention from the very first injection is paramount," Dr. Seo emphasized.

■ Prevention Starts with Injection Intervals and Formulation Choice

Resistance can be substantially reduced by maintaining a minimum interval of three months between sessions and avoiding unnecessarily high-dose or repeated injections. Choosing a pure toxin formulation free of complexing proteins is also a prudent strategy. Patients who notice that results are not lasting as long as before should pause treatment and communicate honestly with their physician.

"This research will heighten awareness of high-dose, repeated injections and lead to more concrete standards for formulation selection and injection interval management. The belief that aesthetic procedures are safe from botulinum toxin resistance — it is time to let that go."

1. Maintain a 3-month injection interval: Botulinum toxin is a protein-based preparation capable of triggering an immune response. Repeat injections within 2 weeks to 1 month can produce an antigen-boosting effect. Avoid repeat sessions within one month whenever possible.

2. Manage all injection sites as a unified schedule: Even when different body areas are targeted, antigen exposure accumulates as long as the same botulinum toxin is administered. Manage the full injection schedule on a 3-month interval basis. (Wrinkles: every 3-4 months, twice per year; jawline reduction: every 6-12 months, once per year.)

3. Exercise caution with high-dose procedures: Single-session high-dose applications such as masseter reduction, calf slimming, and trapezius injections should be approached conservatively from the outset, with careful management of frequency and intervals.

4. Choose a lower-resistance formulation: Pure toxin formulations, from which complexing proteins that stimulate immune responses have been removed, carry a lower risk of resistance.